Sci Pharmtech Corp.TWSE: 4119

List of the Company's elected directors.

· Issued by Sci Pharmtech Corp.
Close
Today's Information

Provided by: SCI Pharmtech, Inc.
SEQ_NO 2 Date of announcement 2022/06/21 Time of announcement 15:08:39
Subject
 List of the Company's elected directors.
Date of events 2022/06/21 To which item it meets paragraph 6
Statement
1.Date of occurrence of the change:2022/06/21
2.Elected or changed position (Please enter institutional director,
institutional supervisor, independent director, natural-person director or
natural-person supervisor):
juristic-person director, independent director, natural-person
director
3.Title and name of the previous position holder:
(1)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Weichyun Wong
(2)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Henry Chen
(3)Director: Mercuries & Associates, Holding Ltd.
 Representative : Ms. Aurora Chen
(4)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Wen-Chih Chou
(5)Independent director: Mr. Ted Tu
(6)Independent director: Mr. Hung-Chih Wu
(7)Independent director: Mr. Chia-Chun Jay Chen
4.Resume of the previous position holder:
(1)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Weichyun Wong
 General manager of SCI Pharmtech, Inc.
(2)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Henry Chen
 Chairman of Mercuries & Associates, Ltd.
(3)Director: Mercuries & Associates, Holding Ltd.
 Representative : Ms. Aurora Chen
 Director of Shanghai American School
(4)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Wen-Chih Chou
 R&D manager of SCI Pharmtech, Inc.
(5)Independent director: Mr. Ted Tu
 Chairman of Hsuan Ho technology Ltd.
(6)Independent director: Mr. Hung-Chih Wu
 General manager of CHENG FONG CHEMICAL CO., LTD.
(7)Independent director: Mr. Chia-Chun Jay Chen
 Professor of Department of Chemistry, National Taiwan Normal University.
5.Title and name of the new position holder:
(1)Director: Mr. Weichyun Wong
(2)Director: Mr. Henry Chen
(3)Director: Mercuries & Associates, Holding Ltd.
 Representative : Ms. Aurora Chen
(4)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Wen-Chih Chou
(5)Independent director: Mr. Ted Tu
(6)Independent director: Mr. Chia-Chun Jay Chen
(7)Independent director: Mr. Vincent Wang
6.Resume of the new position holder:
(1)Director: Mr. Weichyun Wong
 General manager of SCI Pharmtech, Inc.
(2)Director: Mr. Henry Chen
 Chairman of Mercuries & Associates, Ltd.
(3)Director: Mercuries & Associates, Holding Ltd.
 Representative : Ms. Aurora Chen
 Director of Yushan Pharmaceuticals Inc.
(4)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Wen-Chih Chou
 Factory manager of SCI Pharmtech, Inc.
(5)Independent director: Mr. Ted Tu
 Chairman of PharmaEngine, Inc.
(6)Independent director: Mr. Chia-Chun Jay Chen
 Professor of Department of Chemistry, National Taiwan Normal University.
(7)Independent director: Mr. Vincent Wang
 Chairman of SUNSINO DEVELOPMENT ASSOCIATE INC.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):tenure expired
8.Reason for the change:re-election due to tenure expiration
9.Number of shares held by the new position holder when elected:
(1)Director: Mr. Weichyun Wong; 526,970 shares
(2)Director: Mr. Henry Chen;  0 shares
(3)Director: Mercuries & Associates, Holding Ltd.
 Representative : Ms. Aurora Chen;   30,283,358 shares
(4)Director: Mercuries & Associates, Holding Ltd.
 Representative : Mr. Wen-Chih Chou; 30,283,358 shares
(5)Independent director: Mr. Ted Tu; 0 share
(6)Independent director: Mr. Chia-Chun Jay Chen; 0 share
(7)Independent director: Mr. Vincent Wang; 6,000 shares
10.Original term (from __________ to __________):2019/06/21~2022/06/20
11.Effective date of the new appointment:2022/06/21
12.Turnover rate of directors of the same term:NA
13.Turnover rate of independent directors of the same term:NA
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:NA

Earlier from Sci Pharmtech

All Sci Pharmtech news releases